SPRY

ARS Pharmaceuticals Inc

Jun 18 • 04:00PM ET

9.65

-0.25 -2.53 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: HRMY SUPN ALKS PRGO BHC AMRX INDV LNTH TEVA VTRS

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO VHT ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.00	Insider Own	35.05%	Shs Outstand	99.30M	Perf Week	0.63%
Market Cap	958.24M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	-0.08%	Shs Float	64.48M	Perf Month	34.59%
Enterprise Value	853.79M	PEG	-	EPS next Q	-0.48	Inst Own	74.28%	Short Float	39.54%	Perf Quarter	16.97%
Income	-197.98M	P/S	9.68	EPS this Y	-0.57%	Inst Trans	-1.01%	Short Ratio	15.24	Perf Half Y	-9.47%
Sales	98.99M	P/B	15.63	EPS next Y	45.37%	ROA	-64.39%	Short Interest	25.50M	Perf YTD	-17.17%
Book/sh	0.62	P/C	4.77	EPS next 5Y	-	ROE	-136.40%	52W High	18.90 -48.94%	Perf Year	-39.35%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-125.44%	52W Low	6.66 44.89%	Perf 3Y	55.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	74.12%	Volatility	5.13% 6.87%	Perf 5Y	-69.73%
Dividend TTM	-	EV/Sales	8.63	EPS Y/Y TTM	-1130.30%	Oper. Margin	-204.49%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	1.92%	Profit Margin	-200.00%	RSI (14)	58.38	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-76.39%	SMA20	5.99%	Beta	0.91	Target Price	28.80
Payout	-	Debt/Eq	1.57	Sales Q/Q	184.47%	SMA50	12.67%	Rel Volume	1.37	Prev Close	9.90
Employees	163	LT Debt/Eq	1.57	Earnings	May 15 BMO	SMA200	2.83%	Avg Volume	1.67M	Price	9.65
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.22% 2.17%	Trades		Volume	2,275,858	Change	-2.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)